trending Market Intelligence /marketintelligence/en/news-insights/trending/SXZEtkEV0CJx5_TAR7BQbA2 content esgSubNav
In This List

Repros CEO resigns; interim CEO named

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Repros CEO resigns; interim CEO named

Joseph Podolski resigned as president, CEO and board member of Repros Therapeutics Inc. to pursue other interests.

Larry Dillaha, CEO of CavtheRx, has been appointed to serve as interim president and CEO, effective Feb. 2.